Hello,
Here's the first draft of the main paper outline and the main
figures/tables - the way I see it at the moment. I want to highlight
that this is still very preliminary, but I think it's useful to think
about the structure and messages of the paper and put some placeholders.
We're going have a very cool paper out of this project, no doubt about
that :-)
Only writing this outline I truly realized how much material and
exciting results we (will) have. We'll be limited by space though, and
it will be difficult to present everyone's results in the length that
they'd deserve in the main text/figures. My current, preliminary
assignment of the main figures is based on what I know/anticipate of the
results at the moment, how they reflect the unique properties of this
dataset, novelty/scoopability, and how well they work as selling points
to journals.
In order to stay on some kind of schedule, we all (myself included) need
to wrap up the analyses in about 2 weeks.
I expect lots of comments and updates - I definitely need your help
understanding the key messages and best ways to present your analyses.
cheers,
Tuuli
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
On /26/912 21:56 PM, Tuuli Lappalainen wrote:
Hello,
We'll have our regular Geuvadis RNAseq analysis group call on
September 27th at 2pm CET.
Agenda:
- agenda for the whole group call within 2 weeks
- presentations in Santiago de Compostela
- draft of the main paper outline by Tuuli
- we need to come up with a good common statistics (or two) to
describe population variation of different transcriptome features
- Manny will presentation on loff-of-function splice variant effects
Call details:
Germany +49 692 573 804 41 <tel:%2B49%20692%20573%20804%2041>
Netherlands +31 108 920 271 <tel:%2B31%20108%20920%20271>
Spain +34 931 816 661 <tel:%2B34%20931%20816%20661>
Sweden +46 840 309 949 <tel:%2B46%20840%20309%20949>
Switzerland +41 58 262 07 22 <tel:%2B41%2058%20262%2007%2022>
United Kingdom +44 203 370 57 19 <tel:%2B44%20203%20370%2057%2019>
United States +1 646 381 08 89 <tel:%2B1%20646%20381%2008%2089>
/Access code: 611683 /
best regards,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch
_______________________________________________
Geuvadis_rna_analysis mailing list
Geuvadis_rna_analysis(a)lists.crg.es
http://davinci.crg.es/mailman/listinfo/geuvadis_rna_analysis